All Stories

  1. Low-Frequency Magnetic Resonance Imaging Identifies Hand Joint Subclinical Inflammation in Systemic Sclerosis
  2. Is Osteoarthritis Always Associated with Low Bone Mineral Density in Elderly Patients?
  3. A Discrepancy: Calcium Channel Blockers are Effective for the Treatment of Hypertensive Left Ventricular Hypertrophy but Not as Effective for Prevention of Heart Failure
  4. Beta Blockers can Mask not only Hypoglycemia but also Hypotension
  5. Diabetic Cardiomyopathy: Clinical and Metabolic Approach
  6. Hypertensive emergency is characterized by acute hypertension-mediated organ damage but also a life-threatening status
  7. Electrocardiographic criteria which have the best prognostic significance in hypertensive patients with echocardiographic hypertrophy of left ventricle: 15‐year prospective study
  8. Impending hypertensive emergency is frequently considered in guidelines, but neither defined nor explained
  9. Beta blocker rebound phenomenon is important, but we do not know its definition, incidence or optimal prevention strategies
  10. Predictors of Cardiovascular Events in Hypertensive Patients with High Cardiovascular Risk
  11. How should we treat very high blood pressure until we distinguish between hypertensive emergency and urgency?
  12. Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries
  13. Dyslipidemia: Contemporary Therapy Options in Terms of Worldwide Guidelines
  14. Impact of metabolic syndrome on clinical severity and long-term prognosis in patients with myocardial infarction with ST-segment elevation
  15. Sodium-glucose Cotransporter 2 Inhibitors: Potential Cardiovascular and Mortality Benefits
  16. PROGNOSTIC SIGNIFICANCE OF VISIT-TO-VISIT VARIABILITY, MEAN AND MAXIMUM BLOOD PRESSURE IN TREATED HYPERTENSIVE PATIENTS WITH HIGH CARDIOVASCULAR RISK
  17. Significance of asymptomatic hyperuricemia in patients after coronary events
  18. A Critical Approach of Guideline Therapeutic Recommendations for NAFLD
  19. Predictive value of metabolic syndrome definitions in patients with myocardial infarction with ST segment elevation – are they all the same?
  20. Patient with coronary artery disease and hypertension
  21. QTc dispersion and Cornell duration product can predict 10-year outcomes in hypertensive patients with left ventricular hypertrophy
  22. THE EFFECT OF DEGREE AND TYPE OF LEFT VENTRICULAR HYPERTROPHY ON VENTRICULAR ARRHYTHMIAS IN HYPERTENSION
  23. [OP.7B.07] FIFTEEN-YEAR PROGNOSTIC SIGNIFICANCE OF ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH ARTERIAL HYPERTENSION
  24. [PP.01.19] PREDICTORS OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS WITH HIGH CARDIOVASCULAR RISK
  25. [PP.11.34] THE PREVALENCE OF METABOLIC SYNDROME IN PATIENTS WITH HYPERTENSION AND ITS IMPACT ON ASYMPTOMATIC CAROTID ATHEROSCLEROSIS
  26. [PP.05.12] SUBCLINICAL ORGAN DAMAGE IN HYPERTENSIVE PATIENTS WITH HIGH CARDIOVASCULAR RISK – FACTORS CONTRIBUTING TO THE CHANGE OF LEFT VENTRICULAR MASS AND CAROTID INTIMA MEDIA THICKNESS
  27. [PP.18.03] THE IMPACT OF ARTERIAL HYPERTENSION ON MORTALITY IN PATIENTS WITH MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION
  28. [PP.29.11] METABOLIC SYNDROME AS THE PREDICTOR OF NEW CARDIOVASCULAR EVENTS IN PATIENTS WITH MYOCARDIAL INFARCTION TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION
  29. [PP.33.01] EVALUATION OF HYPERTENSIVE PATIENTS
  30. [PP.33.06] SUBCLINICAL ORGAN DAMAGE IN HYPERTENSIVE PATIENTS WITH HIGH CARDIOVASCULAR RISK
  31. [PP.36.06] THE IMPACT OF SERUM URIC ACID ON ASYMPTOMATIC CAROTID ATHEROSCLEROSIS AND RENAL DISEASE IN HYPERTENSIVE PATIENTS
  32. 4B.09
  33. PP.04.19
  34. Motivation and job satisfaction of health workers in a specialized health institution in Serbia
  35. Association of the thickness of carotid intima-media complex and ancle brachial index with coronary disease severity
  36. Impact of depression on sexual dysfunction and HRQoL in CAD patients
  37. Prevalence of arterial hypertension in Serbia
  38. Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
  39. Predictive value of noninvasive markers of atherosclerosis for cardiovascular morbidity and mortality in patients with coronary artery disease (4 years follow-up study)
  40. Eleven years of follow-up of patients with hypertensive left ventricular hypertrophy
  41. Health-related quality of life in patients with coronary artery disease after coronary revascularization
  42. Relation between bone density and certain parameters of lipid status in postmenopausal women
  43. Predictive value of non-invasive parameters in patients with left ventricular hypertrophy during a five-year follow-up period
  44. The clinical significance of antibody determination to cyclic citrullinated peptides in systemic sclerosis
  45. GENDER SPECIFIC PROGNOSTIC DIFFERENCES IN REGARD TO THE REGRESSION OF HYPERTENSIVE LEFT VENTRICULAR HYPERTROPHY (12 YEARS FOLLOW-UP STUDY)
  46. NINE YEARS FOLLOW-UP OF PATIENTS WITH HYPERTENSIVE LEFT VENTRICULAR HYPERTROPHY AND PREDICTIVE VALUE OF NON-INVASIVE PARAMETERS
  47. THE INFLUENCE OF METABOLIC SYNDROME ON THE OCCURRENCE AND SEVERITY OF CAROTID ATHEROSCLEROSIS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY
  48. Do we reach target lipid levels in diabetic and non-diabetic patients with previous myocardial infarction?
  49. Application of secondary prevention measures in patients with coronary artery disease - Republic Serbia
  50. Guidelines for rehabilitation of patients with coronary disease
  51. EFFECTS OF THE EARLY ONE YEAR TREATMENT IN HYPERTENSIVE LEFT VENTRICULAR HYPERTROPHY AND SIGNIFICANCE ON CARDIOVASCULAR EVENTS IN THE FUTURE: PP.22.373
  52. METABOLIC SYNDROME AND ATHEROSCLEROSIS OF CAROTID ARTERIES IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY: PP.2.79
  53. PREDICTIVE VALUE OF NON-INVASIVE PARAMETERS DURING EIGHT YEARS FOLLOW-UP OF PATIENTS WITH HYPERTENSIVE LEFT VENTRICULAR HYPERTROPHY: PP.22.378
  54. THE AFFECT OF THE REGRESSION OF THE LEFT VENTRICULAR HYPERTROPHY OF THE FUNCTIONAL CAPACITY IN HYPERTENSIVE PATIENTS: PP.35.487
  55. Five years prognosis of patients with arterial hypertension and left ventricular hypertrophy
  56. Effects of balneotherapy on the reactants of acute inflammation phase in Ankylosing spondylitis
  57. Evaluation of myocardial function in the presence of left ventricular hypertrophy in athletes and hypertensive patients
  58. Correlation between 24-hour profile of blood pressure and ventricular arrhythmias and their prognostic significance in patients with arterial hypertension
  59. Prognostic value of QTc interval dispersion changes during exercise testing in hypertensive men
  60. Carotid atherosclerosis associated to metabolic syndrome and ischemic heart disease in hypertensive patients with left ventricular hypertrophy
  61. Effect of fosinopril on progression of the asymptomatic carotid atherosclerosis and left ventricular hypertrophy in hypertensive patients
  62. 24-HOUR PULSE PRESSURE AT HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY
  63. IMPACT OF LEFT VENTRICULAR HYPERTROPHY ON REGIONAL MYOCARDIAL VELOCITIES IN ATHLETES AND HYPERTENSIVES HEART
  64. 717 Quantification of regional myocardial function detects super-silent myocardial ischaemia in diabetic patients
  65. The relationship between ventricular arrhythmias, heart rate variability and ventricular systolic function